Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000376545 | SCV000339090 | uncertain significance | not provided | 2016-02-11 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV004529472 | SCV000914376 | uncertain significance | CRB1-related disorder | 2018-10-23 | criteria provided, single submitter | clinical testing | The CRB1 c.2809G>A (p.Ala937Thr) variant is a missense variant that has been reported in two studies, in which it is found in a total of two individuals including in a compound heterozygous state with a second missense variant in an individual with retinitis pigmentosa (Xu et al. 2010) and in a heterozygous state in one individual with Leber congenital amaurosis. It is not clear if other variants were found in the heterozygous individual (Seong et al. 2008). This variant is not reported in individuals with pigmented paravenous chorioretinal atrophy. Control data are unavailable for this variant, which is reported at a frequency of 0.003233 in the East Asian population in the Genome Aggregation Database. One homozygote is also reported in the Genome Aggregation Database. Based on the limited evidence, the p.Ala937Thr variant is classified as a variant of uncertain significance but suspicious for pathogenicity for CRB1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Labcorp Genetics |
RCV001080703 | SCV001099185 | likely benign | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888680 | SCV004706196 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Natera, |
RCV001275656 | SCV001460947 | likely benign | Leber congenital amaurosis | 2020-09-16 | no assertion criteria provided | clinical testing |